Colony Group LLC Bristol Myers Squibb CO Transaction History

Colony Group LLC

$6.66 Billion
Q3 2023

A detailed history of Colony Group LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Colony Group LLC holds 212,434 shares of BMY stock, worth $11.3 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

212,434

Previous 213,056 0.29%

Holding current value

$11.3 Million

Previous $13.6 Million 9.5%

% of portfolio

0.19%

Previous 0.19%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $36,007 - $40,262	-622 Reduced 0.29%	212,434 $12.3 Million
Q2 2023 Aug 15, 2023	SELL	$63.71 - $70.74 $17,074 - $18,958	-268 Reduced 0.13%	213,056 $13.6 Million
Q1 2023 May 16, 2023	SELL	$65.71 - $74.53 $1.2 Million - $1.37 Million	-18,318 Reduced 7.91%	213,324 $14.8 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $401,772 - $475,755	5,867 Added 2.6%	231,642 $16.7 Million
Q3 2022 Nov 15, 2022	BUY	$0.13 - $76.84 $1,661 - $981,861	12,778 Added 6.0%	225,775 $16.1 Million
Q2 2022 Aug 16, 2022	BUY	$72.62 - $79.98 $1.23 Million - $1.35 Million	16,888 Added 8.61%	212,997 $16.4 Million
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $867,913 - $1.04 Million	14,117 Added 7.76%	196,109 $14.3 Million
Q4 2021 Feb 15, 2022	BUY	$53.63 - $62.52 $2.55 Million - $2.97 Million	47,472 Added 35.29%	181,992 $11.3 Million
Q3 2021 Nov 17, 2021	SELL	$59.17 - $69.31 $93,843 - $109,925	-1,586 Reduced 1.17%	134,520 $7.96 Million
Q2 2021 Aug 18, 2021	BUY	$61.91 - $67.42 $31,821 - $34,653	514 Added 0.38%	136,106 $9.1 Million
Q1 2021 May 21, 2021	SELL	$59.34 - $66.74 $307,321 - $345,646	-5,179 Reduced 3.68%	135,592 $8.56 Million
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $292,915 - $331,926	-5,073 Reduced 3.48%	140,771 $8.73 Million
Q3 2020 Nov 17, 2020	SELL	$57.43 - $63.64 $244,249 - $270,660	-4,253 Reduced 2.83%	145,844 $8.79 Million
Q2 2020 Aug 13, 2020	SELL	$54.82 - $64.09 $116,328 - $135,998	-2,122 Reduced 1.39%	150,097 $8.83 Million
Q1 2020 May 18, 2020	SELL	$46.4 - $67.43 $1.45 Million - $2.11 Million	-31,285 Reduced 17.05%	152,219 $8.49 Million
Q4 2019 Feb 18, 2020	BUY	$49.21 - $64.19 $895,228 - $1.17 Million	18,192 Added 11.0%	183,504 $11.8 Million
Q3 2019 Nov 26, 2019	BUY	$42.77 - $50.71 $2.14 Million - $2.54 Million	50,038 Added 43.41%	165,312 $8.38 Million
Q2 2019 Aug 19, 2019	BUY	$44.62 - $49.34 $4.79 Million - $5.3 Million	107,458 Added 1374.85%	115,274 $5.23 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $171,095 - $204,009	3,792 Added 94.23%	7,816 $373,000
Q4 2018 Feb 15, 2019	SELL	$48.76 - $63.23 $148,132 - $192,092	-3,038 Reduced 43.02%	4,024 $209,000
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $26,767 - $30,191	-485 Reduced 6.43%	7,062 $438,000
Q2 2018 Aug 15, 2018	BUY	$50.53 - $62.98 $404 - $503	8 Added 0.11%	7,547 $418,000
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $7,430 - $8,553	124 Added 1.67%	7,539 $477,000
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $45,374 - $49,469	757 Added 11.37%	7,415 $454,000
Q3 2017 Nov 15, 2017	BUY	$55.23 - $63.74 $367,721 - $424,380	6,658	6,658 $424,000

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Colony Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Colony Group LLC with notifications on news.

Account